Considering that some human lung tumors have not only SMAD4 mutation but also triple mutations in KRAS, TP53, and SMAD4 (Supplementary Data 6, 7)54, our findings may address the impact of p53 mutation in Smad4 LOF on the progression of these lung cancers. This evidence concerns the gene TP53 and lung carcinoma.